Clinical Trial Update: Clinical Investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation [NA]

View source ↗

Summary

This update covers the VytronUS Ablation System being investigated for symptomatic drug-refractory paroxysmal atrial fibrillation; the trial status is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• VytronUS Ablation System

Snippet

Sponsor: VytronUS, Inc. | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: UNKNOWN